Clinical Trials Logo

Healthy Participants clinical trials

View clinical trials related to Healthy Participants.

Filter by:

NCT ID: NCT05662215 Recruiting - Clinical trials for Healthy Participants

A Single and Multiple Ascending Dose Study of CK-3828136 in Healthy Adult Participants

Start date: December 6, 2022
Phase: Phase 1
Study type: Interventional

1. Learn about the safety and tolerability of CK-3828136 after a single dose and multiple doses in healthy subjects. 2. Find out how much CK-3828136 is in the blood after a single dose and multiple doses. 3. Determine the effect different doses of CK-3828136 on the pumping function of the heart.

NCT ID: NCT05644977 Recruiting - Clinical trials for Healthy Participants

A Multiple Dose Trial of Emraclidine in Elderly Participants and in Participants With Dementia Due to Alzheimer's Disease

Start date: December 2, 2022
Phase: Phase 1
Study type: Interventional

The primary purpose of the study is to evaluate the safety and tolerability of emraclidine administered orally to healthy elderly participants in Part A (multiple ascending doses) and participants with dementia due to Alzheimer's disease (AD) in Part B.

NCT ID: NCT05604287 Recruiting - Clinical trials for Healthy Participants

Safety, Tolerability, and Pharmacokinetics of ID119031166M With the Exploration of Pharmacodynamic Effects

Start date: October 10, 2022
Phase: Phase 1
Study type: Interventional

This study will evaluate safety, tolerability, and Pharmacokinetics (PK) of ID119031166M with the Exploration of Pharmacodynamic (PD) effects in Healthy Participants.

NCT ID: NCT05537142 Recruiting - Clinical trials for Healthy Participants

A Study to Assess the Phamacokinetics of BV100 in Participants With Varying Degrees of Hepatic Impairment

Start date: September 2, 2022
Phase: Phase 1
Study type: Interventional

To investigate the pharmacokinetics (PK) of rifabutin in subjects with hepatic impairment after single intravenous (IV) infusion of BV100

NCT ID: NCT05346094 Recruiting - Clinical trials for Healthy Participants

Cardiac Normal Values Assessed by Magnetic Resonance Imaging

Start date: January 1, 2022
Phase:
Study type: Observational

This study carried out a study enrolled healthy volunteers to comprehensively provide age and sex specific reference values of the normal cardiac structure and function of Chinese adults, using the steady-state free precession technique (SSFP) as well as reference values for novel cardiovascular magnetic resonance techniques including myocardial strian and tissue characterization.

NCT ID: NCT05339646 Recruiting - Clinical trials for Healthy Participants

A Phase I Clinical Study of SSD8432 in Healthy Adult Subjects

Start date: April 7, 2022
Phase: Phase 1
Study type: Interventional

This is a Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SSD8432 in Healthy Adult Subjects

NCT ID: NCT05303246 Recruiting - Clinical trials for Healthy Participants

A Study Investigating Lu AG22515 in Healthy Adults

Start date: March 18, 2022
Phase: Phase 1
Study type: Interventional

The main goal of this study is to learn more about the safety of a drug called Lu AG22515. During the trial, healthy adult participants will receive a single dose of Lu AG22515 or a placebo (normal saline solution).

NCT ID: NCT05157334 Recruiting - Clinical trials for Rheumatoid Arthritis

The Effect of Deep Breathing and Transcutaneus Electrical Nerve Stimulation on Heart Rate Variability

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

This interventional study aims to investigate the effect of deep breathing (DB) and transcutaneous electrical vagus nerve stimulation (tVNS) on heart rate variability (HRV) in healthy participants and patients with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE). HRV is used as a surrogate measure of vagal nerve tone. The study consists of three sub-projects: Sub-project 1: To compare the effect of one session of DB and one session of non-invasive auricular tVNS on vagal nerve tone measured by HRV in healthy participants and in patients with RA and SLE. The hypotheses is that DB has a similar effect on HRV as non-invasive electrical tVNS. Sub-project 2: A dose-response study in healthy participants comparing the effect of 5, 15 and 30 minutes of DB on HRV. The hypothesis was that HRV increases as a function of the number of minutes the DB is performed in healthy participants. Sub-project 3: To investigate the effect of the optimal dose found in sub-project 2 in patients with RA and SLE measured by HRV, and to investigate its reproducibility by doing it twice.The hypothesis was that HRV increases after DB in patients with RA and SLE, and the effect is reproducible. In all three sub-projects the washout period will be investigated by measuring HRV three times after the intervention. We hypothesise that the effect of DB and tVNS on HRV decreases over time.

NCT ID: NCT05115240 Recruiting - Clinical trials for Healthy Participants

The Effects of a Brief Mindfulness Intervention on Emotional Responses and the Moderating Role of Interoception

Start date: October 1, 2021
Phase: N/A
Study type: Interventional

This study examines the effects of a brief mindfulness intervention (body scan) on emotional responses (e.g., affect, heart rate variability (HRV)) compared to an active control group. Another aim is to assess whether the effects of the mindfulness intervention can be augmented by optimizing positive expectations. The moderating role of interception on the mindfulness intervention's effects will also be examined.

NCT ID: NCT05006547 Recruiting - Clinical trials for Healthy Participants

Peroneal Muscles Response to Expected and Unexpected Falls Among Young and Middle-aged Adults Before and After Neuromuscular Training

Start date: July 1, 2021
Phase:
Study type: Observational

Proper functioning of the ankle musculature, specifically peroneal muscles, is crucial for maintaining balance and reducing the risk for falls. Evidence suggests that a decrease in aspects of neuromuscular control already starts at midlife (45-65 years). However, there is almost no information regarding the function of the ankle muscles at the middle-age as most experiments have compared young (<35 years) and older subjects (>65 years). Moreover, neuromuscular training can improve the function of ankle muscle in response to perturbation; yet, no previous study has compared the level of effectiveness between middle-aged and young adults.